 Dapsone effective therapy skin lesions subacute cutaneous lupus erythematosus urticarial vasculitis patient deficiency deficiency second component complement common hereditary complement deficiency Patients deficiency auto-immune disease process particular systemic lupus erythematosus LE syndrome and/or vasculitic syndrome bacterial infections LE subset subacute cutaneous LE SCLE presence anti-Ro SSA antibodies human leukocyte antigen HLA clinical serologic immunogenetic data patient manifestations Sjogren syndrome urticarial vasculitis photosensitive annular SCLE oral dapsone case dynamic nature LE